700
Views
3
CrossRef citations to date
0
Altmetric
Review

SGLT-2 inhibitors: pharmacokinetics characteristics and effects on lipids

, , ORCID Icon, & ORCID Icon
Pages 1113-1121 | Received 02 Aug 2018, Accepted 24 Oct 2018, Published online: 31 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Emir Muzurović & Dimitri P Mikhailidis. (2020) Impact of glucagon-like peptide 1 receptor agonists and sodium-glucose transport protein 2 inhibitors on blood pressure and lipid profile. Expert Opinion on Pharmacotherapy 21:17, pages 2125-2135.
Read now
Ioanna Papakitsou, George Vougiouklakis, Moses S Elisaf & Theodosios D Filippatos. (2019) Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes. Clinical Pharmacology: Advances and Applications 11, pages 133-143.
Read now
Theodosios D. Filippatos, Angelos Liontos, Ioanna Papakitsou & Moses S. Elisaf. (2019) SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses. Postgraduate Medicine 131:2, pages 82-88.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.